Skip to main content

Table 2 Vitiligo Area Scoring Index scores at baseline and week 12, n = 11

From: Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial

Area   % area of vitiligo (SD) extent of depigmentation
(0,10,25,50,75,90,100) (SD)
VASI score (SD)
hands (0-4%) baseline 1.08 (0.93) 37.27 (35.73) 0.51 (0.56)
  week 12 1.08 (0.93) 35.91 (34.27) 0.50 (0.57)
  change 0.00 p = 0 -1.36 p = 0.21 -0.01 p = 0.21
upper extremities (0-18%) baseline 1.10 (1.69) 34.55 (41.02) 0.70 (1.38)
  week 12 1.10 (1.69) 30.91 (35.48) 0.63 (1.18)
  change 0.00 p = 0 -3.64 p = 0.20 -0.07 p = 0.35
trunk (0-36%) baseline 2.87 (4.04) 69.64 (32.58) 1.66 (1.53)
  week 12 2.85 (4.04) 58.64 (32.95) 1.43 (1.57)
  change -0.02 p = 0.36 -11.00 p = 0.11 -0.22 p = 0.10
lower extremities (0-36%) baseline 2.12 (2.12) 57.73 (29.78) 1.32 (1.57)
  week 12 2.12 (2.13) 50.00 (26.36) 1.13 (1.37)
  change 0.00 p = 0.36 -7.73 p = 0.08 -0.20 p = 0.23
feet (0-6%) baseline 1.14 (1.41) 50.00 (41.17) 0.79 (1.26)
  week 12 1.12 (1.40) 50.00 (41.17) 0.78 (1.26)
  change -0.02 p = 0.36 0.00 p = 0 0.00 p = 0.36
total VASI (0-100%) baseline    4.97 (4.74)
  week 12    4.47 (4.69)
  change    -0.51 p = 0.02
  1. SD, standard deviation.